CHICAGO (October 31, 2013) – Cancer Treatment Centers of America (CTCA) at Midwestern Regional Medical Center (Midwestern) was named Top Performer on Key Quality Measures® by The Joint Commission, the leading accreditor of health care organizations in America. CTCA at Midwestern was recognized by The Joint Commission for exemplary performance in using evidence-based clinical processes that are shown to improve care for certain conditions.
CTCA at Midwestern is one of only 35 hospitals in Illinois earning the distinction of Top Performer on Key Quality Measures for attaining and sustaining excellence in accountability measure performance. CTCA at Midwestern was recognized for its achievement in surgical services. In 2012, the hospital celebrated its surgical capabilities with the opening of a 25,000 square foot surgical center. This new center provides the opportunity for cancer patients to benefit from expanded services in minimally invasive neurosurgery, Hyperthermic Intraperitoneal Chemoperfusion (HIPEC), Intraoperative Radiation Therapy (IORT), orthopedic oncology and reconstructive surgery.
“Every day, we make a commitment to our patients that we will provide them with compassionate care that, above all else, is safe and effective,” said President and CEO of CTCA at Midwestern Scott Jones, FACHE, MHA. “This is especially true for patients who seek oncology care for advanced surgical options that offer powerful, innovative therapy against cancer. That is why at CTCA at Midwestern we hold ourselves accountable to transparent quality reporting. We are honored to be recognized as a Joint Commission Top Performer on Key Quality Measures,” said Jones.
As a Top Performer on Key Quality Measures, CTCA at Midwestern met criteria illustrating 1) cumulative performance of 95 percent or above across all reported accountability measures; 2) performance of 95 percent or above on each and every reported accountability measure where there are at least 30 denominator cases; and 3) at least one core measure set that has a composite rate of 95 percent or above, and (within that measure set) all applicable individual accountability measures have a performance rate of 95 percent or above.
“CTCA at Midwestern and all the Top Performer hospitals have demonstrated an exceptional commitment to quality improvement and they should be proud of their achievement,” said President and CEO of The Joint Commission Mark R. Chassin, MD, FACP, MPP, MPH. “We have much to celebrate this year. Nearly half of our accredited hospitals have attained or nearly attained the Top Performer distinction. This truly shows that we are approaching a tipping point in hospital quality performance that will directly contribute to better health outcomes for patients.”
In addition to being included in the recent release of The Joint Commission’s “Improving America’s Hospitals” annual report, CTCA at Midwestern will be recognized on The Joint Commission’s Quality Check website (www.qualitycheck.org). The Top Performer program will be featured in the December issues of The Joint Commission Perspectives and The Source.
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America Global, Inc. (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-based supportive therapies designed to help patients physically and emotionally by enhancing their quality of life while managing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Consistently rated among U.S. hospitals that deliver the highest quality of care and patient experience, CTCA provides patients and their families with comprehensive information about their treatment options and encourages their active participation in treatment decisions. For more information, visit cancercenter.com, Facebook.com/cancercenter and Twitter.com/cancercenter.